- Open
- 74.33
- High
- 74.33
- Low
- 72.30
- Close
- 73.50
- Change
- -2.20 (-2.98%)
- Volume
- 853,861
| 30 Sept 2026 | 16:33:18 | Dividend Declaration |
| 30 Sept 2026 | 16:21:53 | Director/PDMR Shareholding |
| 24 Sept 2026 | 07:00:07 | Half-year Financial Report |
| 23 Sept 2026 | 16:00:00 | Net Asset Value(s) and Monthly Factsheet |
| 25 Mar 2026 | Annual Report and Financial Statements for the year ended 31 December 2025 | |
| 1 Jan 2026 | Annual_Report_2025 | |
| 10 Apr 2025 | Annual Financial Report |
BioPharma Credit PLC specializes in providing debt financing to companies within the life sciences sector. It primarily invests in corporate and royalty debt secured by cash flows from the sales of approved life sciences products. The trust aims to generate long-term shareholder returns, predominantly through sustainable income distributions. Managed by Pharmakon Advisors, BioPharma Credit focuses on building a diversified portfolio with a strong emphasis on cash flow visibility and stability.
| 30 Sept 2026 | 16:33:18 | Dividend Declaration |
| 30 Sept 2026 | 16:21:53 | Director/PDMR Shareholding |
| 24 Sept 2026 | 07:00:07 | Half-year Financial Report |
| 23 Sept 2026 | 16:00:00 | Net Asset Value(s) and Monthly Factsheet |
| 25 Mar 2026 | Annual Report and Financial Statements for the year ended 31 December 2025 | |
| 1 Jan 2026 | Annual_Report_2025 | |
| 10 Apr 2025 | Annual Financial Report |
BioPharma Credit PLC specializes in providing debt financing to companies within the life sciences sector. It primarily invests in corporate and royalty debt secured by cash flows from the sales of approved life sciences products. The trust aims to generate long-term shareholder returns, predominantly through sustainable income distributions. Managed by Pharmakon Advisors, BioPharma Credit focuses on building a diversified portfolio with a strong emphasis on cash flow visibility and stability.
| 23 Sept 2026 |
| 12:17:18 |
| Holding(s) in Company |
| 23 Sept 2026 |
| 12:17:18 |
| Holding(s) in Company |
| Issuer | Mkt cap | 1Y |
|---|---|---|
BPCRBiopharma Credit PLC | $100.98bn | +0.1% |
| $2.41bn | +0.2% | |
| $806m | +0.5% | |
| $324m | +0.1% |
| Issuer | Mkt cap | 1Y |
|---|---|---|
BPCRBiopharma Credit PLC | $100.98bn | +0.1% |
| $2.41bn | +0.2% | |
| $806m | +0.5% | |
| $324m | +0.1% |